Search Orphan Drug Designations and Approvals
-
Generic Name: | Sodium ascorbate and menadione sodium bisulfite |
---|---|
Date Designated: | 07/31/2007 |
Orphan Designation: | Treatment of metastatic or locally advanced inoperable transitional cell carcinoma of the urothelium (stage III and IV bladder cancer) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
IC-MedTech Corporation 9902 Indian Creek Lane San Diego, California 92021 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-